×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Fabino Enterprises Ltd | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd | 2.21 | -1.32 | NA | -5.38 | 0 | |
| AstraZeneca Pharma India Limited | 6167.0 | 325.9 | 6115.7 | 13.04 | 22,029 | 104.0 |
| Wockhardt Limited | 9130.0 | 610.0 | 8880.0 | 3.61 | 21717 | 426.0 |
| Eris Lifesciences Limited | 8074.7 | 1088.3 | 8074.5 | 7.31 | 21597 | 55.8 |
AstraZeneca Pharma India Ltd., with Security Code 506820, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2025 | Jun 2025 | Sep 2025 | Sep 2025 | Dec 2025 | Dec 2025 | Dec 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 480.5 | 526.3 | 559.1 | 559.1 | 611.6 | 611.6 | 611.6 | 611.6 |
| Expenses | 394.0 | 445.2 | 483.9 | 483.9 | 566.7 | 566.7 | 566.7 | 566.7 |
| Operating Profit | 86.5 | 81.1 | 75.2 | 75.2 | 44.8 | 44.8 | 44.8 | 44.8 |
| OPM % | 17.99% | 15.41% | 13.45% | 13.45% | 7.33% | 7.33% | 7.33% | 7.33% |
| Other Income | 10.5 | 10.9 | 0.9 | 0.9 | 6.6 | 6.6 | 6.6 | 6.6 |
| Interest | 0.7 | 0.7 | 0.7 | 0.7 | 1.1 | 1.1 | 1.1 | 1.1 |
| Depreciation | 17.7 | 16.6 | 2.6 | 2.6 | 3.8 | 3.8 | 3.8 | 3.8 |
| Profit before tax | 84.2 | 75.1 | 78.1 | 78.1 | 45.1 | 45.1 | 45.1 | 45.1 |
| Tax % | -25.7% | 25.3% | 25.5% | -25.5% | 30% | 30% | 30% | 30% |
| Net Profit | 58.3 | 55.8 | 54.2 | 54.2 | 32.6 | 32.6 | 32.6 | 32.6 |
| EPS in Rs | 0 | 22.33 | 21.69 | 0 | 13.04 | 13.04 | 13.04 | 13.04 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 12% |
| 3 Years: | 17% |
| TTM: | 35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 22% |
| 3 Years: | 18% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 21% |
| 3 Years: | 46% |
| 1 Year: | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|